CRVO Stock Predictions
| Recent CRVO Stock Price | CRVO Stock Predictions | |
| $23.82 |  +99.41% |
$47.50 |
| Recent CRVO Analyst Ratings Breakdown, Making CRVO Stock Predictions | ||||
|---|---|---|---|---|
| Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
| Strong buy ratings: | 1 | 1 | 1 | 0 |
| Buy ratings: | 0 | 0 | 0 | 0 |
| Hold ratings: | 0 | 0 | 0 | 0 |
| Sell ratings: | 0 | 0 | 0 | 0 |
| Strong sell ratings: | 0 | 0 | 0 | 0 |
| Average rating: | 1.0 | 1.0 | 1.0 | 0.0 |
For the CRVO stock predictions from the analysts covering CervoMed Inc, we have collected all of the individual CRVO stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 2 different analysts covering CRVO (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since CRVO stock predictions may vary widely, another useful metric to consider is the median CRVO stock prediction, which represents the price at which half of the analysts
made CRVO stock predictions that were higher and half made CRVO stock predictions that were lower. This makes for a different take on the CRVO stock predictions out there, as compared to average or mean.
And that median across all the individual CRVO stock predictions was: $47.5 as of 2024-04-29.
The very highest of the CRVO stock predictions for one year price target was $65.0, while the very lowest of the CRVO stock predictions in the analyst group was
$30.0 (with a standard deviation of $24.748). Get the latest Zacks research report on CRVO — FREE
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
• GES Stock Predictions
• GLDD Stock Predictions
• HBI Stock Predictions
• ACER Stock Predictions
• HUYA Stock Predictions
• MTCH Stock Predictions
• RLGT Stock Predictions
• WMT Stock Predictions
• LPX Stock Predictions
|
|||||||||
|
|
|
|
|
|
Free Email Alerts:
Avg. Broker Rec.
|
Strong Buy (4.00 out of 4) 95th percentile
(ranked higher than approx. 95% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com |
|
|
